Chongkundang Holdings Corp (001630)
Market Closed
8 Dec, 06:30
KRX SM KRX SM Primary ₩
48,150. 00
-600
-1.23%
₩
232.55B Market Cap
- P/E Ratio
5,600% Div Yield
7,037 Volume
- Eps
₩ 48,750
Previous Close Day Range
48,100 48,800
Year Range
40,700 59,300
Want to track 001630 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 70 days
Summary
001630 closed today lower at ₩48,150, a decrease of 1.23% from yesterday's close, completing a monthly increase of 6.76% or ₩3,050. Over the past 12 months, 001630 stock gained 0.31%.
001630 is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2025, exceeded the consensus estimates by 2,815.05%. On average, the company has surpassed earnings expectations by 1,677.67%, based on the last three reports. The next scheduled earnings report is due on Feb 16, 2026.
Chongkundang Holdings Corp has completed 1 stock splits, with the recent split occurring on Dec 06, 2013.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).
Chongkundang Holdings Corp (001630) FAQ
What is the stock price today?
The current price is ₩48,150.00.
On which exchange is it traded?
Chongkundang Holdings Corp is listed on KRX SM.
What is its stock symbol?
The ticker symbol is 001630.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 5,600%.
What is its market cap?
As of today, the market cap is 232.55B.
When is the next earnings date?
The next earnings report will release on Feb 16, 2026.
Has Chongkundang Holdings Corp ever had a stock split?
Chongkundang Holdings Corp had 1 splits and the recent split was on Dec 06, 2013.
Chongkundang Holdings Corp Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Hee-Nam Choi CEO | KRX SM Exchange | KR7001630003 ISIN |
| South Korea Country | 37 Employees | - Last Dividend | 6 Dec 2013 Last Split | - IPO Date |
Overview
Chong Kun Dang Holdings Corp. is a well-established entity in the pharmaceutical industry, focusing on the manufacture and distribution of pharmaceutical products. With its inception in 1941, it has grown to serve not only the domestic market in South Korea but also an international clientele. The headquarters of Chong Kun Dang Holdings Corp. is located in Seoul, South Korea, indicating its central role in the country’s pharmaceutical landscape. Through decades of operation, the company has built a reputation for delivering quality pharmaceutical products, contributing to healthcare and medical treatments worldwide.
Products and Services
Chong Kun Dang Holdings Corp. offers a diverse portfolio of pharmaceutical products that cater to a wide range of medical needs. The company's products and services include:
- Prescription Medicines: These include drugs for various diseases and conditions, requiring a doctor's prescription for purchase. Chong Kun Dang Holdings Corp. invests in research and development to bring innovative drugs to the market, aiding in the treatment of complex health conditions.
- Over-the-Counter (OTC) Drugs: Catering to common health issues, these drugs are available without a prescription, offering convenience and immediate relief to consumers. The range includes pain relievers, cold and allergy medications, and digestive aids, among others.
- Biopharmaceuticals: Leveraging biotechnology, the company develops biopharmaceutical products that include vaccines and biosimilar drugs. These products play a crucial role in preventive healthcare and the treatment of chronic conditions, offering new hope for patients.
- Health Supplements: Understanding the growing focus on preventive healthcare, Chong Kun Dang Holdings Corp. offers a range of health supplements. These products aim to support overall health and well-being, complementing diets and lifestyle choices.
Contact Information
Address: 8, Chungjeong-ro
Phone: 82 2 6373 0600
2025 © Marketlog. All Rights Reserved.
